Department of Molecular Biology, Howard Hughes Medical Institute , Massachusetts General Hospital, Boston, United States; Department of Systems Biology, Harvard Medical School, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United States
Shao-En Ong
Broad Institute of MIT and Harvard, Cambridge, United States
Olga Goldberger
Department of Molecular Biology, Howard Hughes Medical Institute , Massachusetts General Hospital, Boston, United States
Jun Peng
Department of Molecular Biology, Howard Hughes Medical Institute , Massachusetts General Hospital, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United States
Rohit Sharma
Department of Molecular Biology, Howard Hughes Medical Institute , Massachusetts General Hospital, Boston, United States
Dawn A Thompson
Broad Institute of MIT and Harvard, Cambridge, United States
Scott B Vafai
Department of Molecular Biology, Howard Hughes Medical Institute , Massachusetts General Hospital, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United States
Andrew G Cox
Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States
Eizo Marutani
Department of Anesthesia, Critical Care, and Pain Medicine, Masaschusetts General Hospital, Boston, United States
Fumito Ichinose
Department of Anesthesia, Critical Care, and Pain Medicine, Masaschusetts General Hospital, Boston, United States
Wolfram Goessling
Broad Institute of MIT and Harvard, Cambridge, United States; Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States
Aviv Regev
Broad Institute of MIT and Harvard, Cambridge, United States; Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States
Steven A Carr
Broad Institute of MIT and Harvard, Cambridge, United States
Clary B Clish
Broad Institute of MIT and Harvard, Cambridge, United States
Department of Molecular Biology, Howard Hughes Medical Institute , Massachusetts General Hospital, Boston, United States; Department of Systems Biology, Harvard Medical School, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United States
Mitochondrial dysfunction is associated with a spectrum of human disorders, ranging from rare, inborn errors of metabolism to common, age-associated diseases such as neurodegeneration. How these lesions give rise to diverse pathology is not well understood, partly because their proximal consequences have not been well-studied in mammalian cells. Here we provide two lines of evidence that mitochondrial respiratory chain dysfunction leads to alterations in one-carbon metabolism pathways. First, using hypothesis-generating metabolic, proteomic, and transcriptional profiling, followed by confirmatory experiments, we report that mitochondrial DNA depletion leads to an ATF4-mediated increase in serine biosynthesis and transsulfuration. Second, we show that lesioning the respiratory chain impairs mitochondrial production of formate from serine, and that in some cells, respiratory chain inhibition leads to growth defects upon serine withdrawal that are rescuable with purine or formate supplementation. Our work underscores the connection between the respiratory chain and one-carbon metabolism with implications for understanding mitochondrial pathogenesis.